Sign in
Taking peopleNo phase

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients

Key facts

Who runs it
National Institute of Mental Health, Czech Republic
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
62 people, planned
Started
15 Nov 2022
Expected to end
30 Dec 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Exposure Therapy (Virtual Reality)
  • Cognitive flexibility training
  • Standard CBT program without VR interventions
Record updated
24 November 2025

Who can take part

Age
17 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11
  • Fluent in Czech

Who cannot take part

  • Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics
  • Cardiostimulator and mental implants
  • Any other psychiatric, neurological and serious somatic illness
  • Contradictions to using a virtual reality (e.g., epilepsy, balance problems)
  • Substance abuse
  • Pregnancy

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in Czechia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly assigned to one of the following interventions: a) exposure condition - the group with a standard CBT program enriched with exposure therapy in VR (VRET), b) control condition 1 - the group with a standard CBT program enriched with VR cognitive training aimed at cognitive flexibility or c) control condition 2 - standard CBT program without any additional VR intervention. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.

The 3 groups in the trial

  • Virtual reality exposureTreatment being tested

    Participants complete 6-week CBT program with five 30-40-minute sessions of exposure administered via a virtual reality headset (once a week). The intervention involves exposure to various symptom provoking scenarios in the virtual house environment - "OCD house". Scenarios can be adjusted to distinct OCD dimensions: contamination/cleaning, fear-of-harm/checking, symmetry/ordering. Stimuli can be also freely combined across dimensions, so that the scenarios fit to individual needs.

    Treatment: Exposure Therapy (Virtual Reality)

  • Cognitive flexibility trainingExisting treatment, for comparison

    Control group attends 6-week CBT program with five sessions of 30-40 minutes of cognitive training via virtual reality headset using "VRcity" cognitive training games.

  • Standard CBT without additional VR treatmentExisting treatment, for comparison

    Control group completes the standard 6-week CBT program only, with no VR sessions.

    Treatment: Standard CBT program without VR interventions

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Virtual Reality Exposure Therapy in Patients With Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients
Criteria questions
Built from NCT07245134, who can take part
Record updated
24 November 2025